INSYS

INSYQ OTCMKTS
0.2400
-0.0100
-4.00%
Delisted 15:53 07/19 EDT
Open
0.2525
Prev Close
0.2500
High
0.2600
Low
0.2250
Volume
97.93K
Avg Vol (3M)
3.80M
52 Week High
11.65
52 Week Low
0.1420
% Turnover
0.13%
Market Cap
17.90M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers INSYS INSYQ stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States. Subsys delivers a liquid fentanyl formulation in approximately 100, 200, 400, 600, 800, 1,200 and 1,600 micrograms (mcg) dosages. The Company's lead dronabinol product candidate is Syndros, which is under review for approval at the Food and Drug Administration. In addition, the Company is evaluating sublingual spray, inhaled and intravenous formulations of dronabinol in preclinical studies.
MORE >

Recently

Name
Price
%Change